First Trust Advisors LP Logic Bio Therapeutics, Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$5.41 - $9.45 $70,925 - $123,889	-13,110 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$4.25 - $8.46 $4,879 - $9,712	1,148 Added 9.6%	13,110 $111,000
Q1 2020 May 06, 2020	SELL	$4.06 - $11.0 $9,415 - $25,509	-2,319 Reduced 16.24%	11,962 $59,000
Q4 2019 Feb 03, 2020	SELL	$7.01 - $11.01 $827 - $1,299	-118 Reduced 0.82%	14,281 $103,000
Q3 2019 Nov 04, 2019	BUY	$6.97 - $13.46 $100,361 - $193,810	14,399 New	14,399 $156,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.